Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: Analysis of Gynecologic Oncology Group Trials Academic Article uri icon

Overview

MeSH Major

  • African Americans
  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin
  • Health Status Disparities
  • Ovarian Neoplasms
  • Paclitaxel

abstract

  • When they received similar treatment, there was no difference in clinical outcome between black women and white women with advanced stage epithelial ovarian cancer when they received similar treatment as participants in Gynecologic Oncology Group clinical trials. Black patients may experience less severe gastrointestinal toxicity or leukopenia compared with whites when treated with platinum-based chemotherapy.

publication date

  • September 15, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4459778

Digital Object Identifier (DOI)

  • 10.1002/cncr.24482

PubMed ID

  • 19536873

Additional Document Info

start page

  • 4210

end page

  • 7

volume

  • 115

number

  • 18